Literature DB >> 7529262

Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs.

J M Hare1, J F Keaney, J L Balligand, J Loscalzo, T W Smith, W S Colucci.   

Abstract

In vitro studies indicate that muscarinic cholinergic inhibition of beta-adrenergic cardiac responses may be modulated in part by nitric oxide (NO). To evaluate the role of NO in parasympathetic inhibition of the beta-adrenergic contractile response in vivo, we assessed the inotropic response to dobutamine before and during bilateral vagus nerve stimulation in closed-chest dogs. Dobutamine administration and vagal stimulation were repeated during intracoronary infusion of the NO synthase inhibitor NG-monomethyl-L-arginine (L-NMMA, 10 mumol/min) and again following infusion of L-arginine (100 mg/kg). In eight dogs, intracoronary dobutamine infusion at rates of 25 and 50 micrograms/min increased peak +dP/dt by 131 +/- 24 and 168 +/- 22%, respectively (P < 0.0001). Vagal stimulation (2.5 Hz) attenuated the responses to dobutamine (25 and 50 micrograms/min) by 23 +/- 4 and 21 +/- 4%, respectively (P < 0.001). L-NMMA reduced (by 44-62%; P < 0.001) and L-arginine restored vagal inhibition of the dobutamine-stimulated inotropic response. In a second group of nine dogs, dobutamine was administered systemically to assure a constant concentration in the coronary circulation. Vagal stimulation (2.5 Hz) attenuated the dobutamine-stimulated inotropic response (2.5 and 5.0 micrograms/kg per min) by 40 +/- 12% and 57 +/- 8%, respectively (P < 0.004). As with intracoronary dobutamine, L-NMMA diminished and L-arginine restored vagal inhibition of the inotropic response to dobutamine. Intracoronary infusion of atropine (12 micrograms/min) abolished the vagal inhibitory effect, and intracoronary infusion of 8-bromo-cyclic GMP (1 and 10 mM) caused a dose-dependent attenuation of the dobutamine-stimulated increase in +dP/dt. These data suggest that NO mediates, at least in part, vagal inhibition of the inotropic response to beta-adrenergic stimulation by dobutamine, and thus may play a role in normal physiologic regulation of myocardial autonomic responses.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7529262      PMCID: PMC295439          DOI: 10.1172/JCI117664

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  41 in total

1.  Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells.

Authors:  H C Hartzell; R Fischmeister
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

2.  Muscarinic receptor stimulation and cyclic AMP-dependent effects in guinea-pig ventricular myocardium.

Authors:  R Schmied; M Korth
Journal:  Br J Pharmacol       Date:  1990-02       Impact factor: 8.739

3.  Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium.

Authors:  J L Balligand; D Ungureanu; R A Kelly; L Kobzik; D Pimental; T Michel; T W Smith
Journal:  J Clin Invest       Date:  1993-05       Impact factor: 14.808

4.  L-NG-monomethyl arginine and L-NG-nitro arginine inhibit non-adrenergic, non-cholinergic relaxation of the mouse anococcygeus muscle.

Authors:  A Gibson; S Mirzazadeh; A J Hobbs; P K Moore
Journal:  Br J Pharmacol       Date:  1990-03       Impact factor: 8.739

5.  Vagal stimulation attenuates sympathetic enhancement of left ventricular function.

Authors:  R J Henning; I R Khalil; M N Levy
Journal:  Am J Physiol       Date:  1990-05

6.  A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation.

Authors:  D D Rees; R M Palmer; H F Hodson; S Moncada
Journal:  Br J Pharmacol       Date:  1989-02       Impact factor: 8.739

7.  Nitric oxide production within cardiac myocytes reduces their contractility in endotoxemia.

Authors:  A J Brady; P A Poole-Wilson; S E Harding; J B Warren
Journal:  Am J Physiol       Date:  1992-12

8.  Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.

Authors:  W S Colucci; A R Denniss; G F Leatherman; R J Quigg; P L Ludmer; J D Marsh; D F Gauthier
Journal:  J Clin Invest       Date:  1988-04       Impact factor: 14.808

9.  Control of cardiac muscle cell function by an endogenous nitric oxide signaling system.

Authors:  J L Balligand; R A Kelly; P A Marsden; T W Smith; T Michel
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

Review 10.  Autonomic mechanisms regulating myocardial contractility in conscious animals.

Authors:  A M Fujii; S F Vatner
Journal:  Pharmacol Ther       Date:  1985       Impact factor: 12.310

View more
  30 in total

1.  beta(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility.

Authors:  P Varghese; R W Harrison; R A Lofthouse; D Georgakopoulos; D E Berkowitz; J M Hare
Journal:  J Clin Invest       Date:  2000-09       Impact factor: 14.808

Review 2.  Inflammatory cytokines and nitric oxide in heart failure and potential modulation by vagus nerve stimulation.

Authors:  Weiwei Li; Brian Olshansky
Journal:  Heart Fail Rev       Date:  2011-03       Impact factor: 4.214

3.  Inhibition of nitric oxide synthase augments the positive inotropic effect of nitric oxide donors in the rat heart.

Authors:  G Müller-Strahl; K Kottenberg; H G Zimmer; E Noack; G Kojda
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

4.  Stretch-induced programmed myocyte cell death.

Authors:  W Cheng; B Li; J Kajstura; P Li; M S Wolin; E H Sonnenblick; T H Hintze; G Olivetti; P Anversa
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

5.  Alterations in inotropy, nitric oxide and cyclic GMP synthesis, protein phosphorylation and ADP-ribosylation in the endotoxin-treated rat myocardium and cardiomyocytes.

Authors:  P V Sulakhe; L Sandirasegarane; J P Davis; X T Vo; W J Costain; R R Mainra
Journal:  Mol Cell Biochem       Date:  1996 Oct-Nov       Impact factor: 3.396

6.  Muscarinic 2 receptors modulate cardiac proteasome function in a protein kinase G-dependent manner.

Authors:  Mark J Ranek; Curtis K Kost; Chengjun Hu; Douglas S Martin; Xuejun Wang
Journal:  J Mol Cell Cardiol       Date:  2014-02-05       Impact factor: 5.000

7.  Muscarinic cholinergic regulation of cardiac myocyte ICa-L is absent in mice with targeted disruption of endothelial nitric oxide synthase.

Authors:  X Han; I Kubota; O Feron; D J Opel; M A Arstall; Y Y Zhao; P Huang; M C Fishman; T Michel; R A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

8.  Nitric oxide inhibits creatine kinase and regulates rat heart contractile reserve.

Authors:  W L Gross; M I Bak; J S Ingwall; M A Arstall; T W Smith; J L Balligand; R A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

9.  Post-exercise heart rate recovery independently predicts mortality risk in patients with chronic heart failure.

Authors:  Yi-Da Tang; Thomas A Dewland; Detlef Wencker; Stuart D Katz
Journal:  J Card Fail       Date:  2009-08-05       Impact factor: 5.712

10.  Acute vagal stimulation attenuates cardiac metabolic response to β-adrenergic stress.

Authors:  Claudio Vimercati; Khaled Qanud; Itamar Ilsar; Gianfranco Mitacchione; Roberto Sarnari; Daniella Mania; Ryan Faulk; William C Stanley; Hani N Sabbah; Fabio A Recchia
Journal:  J Physiol       Date:  2012-09-10       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.